Search results
Results from the WOW.Com Content Network
Of the drugs that cause DIL, hydralazine has been found to cause a higher incidence. Hydralazine is a medication used to treat high blood pressure. Approximately 5% of the patients who have taken hydralazine over long periods of time and in high doses have shown DIL-like symptoms. [8] Many of the other drugs have a low to very low risk to ...
Lupus is typically treated with anti-inflammatory medicines like ibuprofen, hydroxychloroquine for fatigue and skin and joint problems and with steroid tablets, injections and creams for kidney ...
Childhood-onset systemic lupus erythematosus (i.e., cSLE), also termed juvenile-onset systemic lupus erythematosus, juvenile systemic lupus erythematosus, and pediatric systemic lupus erythematosus, is a form of the chronic inflammatory and autoimmune disease, systemic lupus erythematosus (i.e., SLE), that develops in individuals up to 18 years old. [1]
However, the use of live vaccines (such as for herpes zoster or polio) are no longer commonplace in the U.S., and so this risk is unlikely to be a consideration for most people with lupus. Taken ...
Lupus erythematosus is a collection of autoimmune diseases in which the human immune system becomes hyperactive and attacks healthy tissues. [1] Symptoms of these diseases can affect many different body systems, including joints, skin, kidneys, blood cells, heart, and lungs.
Now, a study published Wednesday in the journal Nature outlines a clear pathway for how the disease likely develops, pointing to abnormalities in the immune systems of people with lupus.
Patients with SLE have higher levels of DNA damage than normal subjects, and several proteins involved in the preservation of genomic stability show polymorphisms, some of which increase the risk for SLE development. [76] Defective DNA repair is a likely mechanism underlying lupus development. [77]
A discoid lupus erythematosus lesion. Discoid lupus erythematosus is one of the most common cutaneous diseases characterized by an attack on healthy epidermal tissue by the immune system leading to lesions on the skin, inflammation, and rashes. Localized DLE lesions will occur on the face, ears, and scalp.